7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Myxoma virus M013 protein antagonizes NF-κB and inflammasome pathways via distinct structural motifs

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Among the repertoire of immunoregulatory proteins encoded by myxoma virus, M013 is a viral homologue of the viral pyrin domain-only protein (vPOP) family. In myeloid cells, M013 protein has been shown to inhibit both the inflammasome and NF-κB signaling pathways by direct binding to ASC1 and NF-κB1, respectively. In this study, a three-dimensional homology model of the M013 pyrin domain (PYD) was built based on similarities to known PYD structures. A distinctive feature of the deduced surface electrostatic map of the M013 PYD is the presence of a negatively region consisting of numerous aspartate and glutamate residues in close proximity. Single-site mutations of aspartate and glutamate residues reveal their role in interactions with ASC-1. The biological significance of charge complementarity in the M013–ASC-1 interaction was further confirmed by functional assays of caspase-1 activation and subsequent secretion of cytokines. M013 also has a unique 33-residue C-terminal tail that follows the N-terminal PYD, and it is enriched in positively charged residues. Deletion of the tail of M013 significantly inhibited the interactions between M013 and NF-κB1, thus compromising the ability of the viral protein to suppress the secretion of pro-inflammatory cytokines. These results demonstrate that vPOP M013 exploits distinct structural motifs to regulate both the inflammasome and NF-κB pathways.

          Related collections

          Author and article information

          Journal
          J Biol Chem
          J. Biol. Chem
          jbc
          jbc
          JBC
          The Journal of Biological Chemistry
          American Society for Biochemistry and Molecular Biology (11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A. )
          0021-9258
          1083-351X
          24 May 2019
          2 April 2019
          : 294
          : 21
          : 8480-8489
          Affiliations
          From the []Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida 32611,
          the [§ ]Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, Arizona 85281, and
          the []School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland
          Author notes
          [3 ] To whom correspondence may be addressed. E-mail: Amir.Khan@ 123456tcd.ie .
          [4 ] To whom correspondence may be addressed. E-mail: lewin@ 123456ufl.edu .
          [5 ] To whom correspondence may be addressed. E-mail: grantmcf@ 123456asu.edu .
          [1]

          These authors contributed equally to this work.

          [2]

          Present address: Dept. of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida 33458.

          Edited by Charles E. Samuel

          Author information
          https://orcid.org/0000-0002-4192-9727
          https://orcid.org/0000-0002-2556-3526
          Article
          PMC6544859 PMC6544859 6544859 RA118.006040
          10.1074/jbc.RA118.006040
          6544859
          30940649
          cc1bda48-1732-4dd7-b4e4-d5968f32c24d
          © 2019 Garg et al.

          Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.

          History
          : 28 September 2018
          : 12 February 2019
          Funding
          Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) , open-funder-registry 10.13039/100000060;
          Award ID: AI100987
          Award Recipient : Award Recipient : Award Recipient : Award Recipient :
          Funded by: Science Foundation Ireland (SFI) , open-funder-registry 10.13039/501100001602;
          Award ID: SFI-12/IA/1239
          Award Recipient :
          Funded by: ASU | Biodesign Institute, Arizona State University , open-funder-registry 10.13039/100007727;
          Award ID: start-up
          Award Recipient :
          Categories
          Microbiology

          inflammasome,poxvirus,myxoma virus,immune evasion,host-pathogen interaction,NF-kappa B (NF-KB),ASC-1,PYRIN domain,innate immunity

          Comments

          Comment on this article